Pfizer says has approval in Japan for COVID vaccine for children aged 5-11

1 minute read

A health worker fills a syringe with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at the Tokyo Dome, the home ground of the Japanese professional baseball team Yomiuri Giants which is being used as a large-scale coronavirus disease (COVID-19) vaccination center, in Tokyo, Japan, August 16, 2021. REUTERS/Issei Kato

Register now for FREE unlimited access to Reuters.com

TOKYO, Jan 21 (Reuters) - Pfizer Inc (PFE.N) said on Friday it received special approval in Japan for its COVID-19 vaccine to be given to children aged 5-11.

The mRNA-type vaccine developed by Pfizer and BioNTech SE has been the most commonly used in Japan for protection against the coronavirus so far.

Register now for FREE unlimited access to Reuters.com
Reporting by Rocky Swift; Editing by Jacqueline Wong

Our Standards: The Thomson Reuters Trust Principles.